Medicine and Dentistry
Afferent Pupillary Defect
16%
Agents Acting on the Eye
18%
Aneurysm
11%
Arteritic Anterior Ischemic Optic Neuropathy
47%
Biopsy
31%
Brain Pseudotumor
24%
Carotid-Cavernous Fistula
31%
Cavernous Sinus
26%
Cerebrospinal Fluid
13%
Craniotomy
15%
Diagnosis
16%
Diplopia
26%
Disease
37%
Exophthalmos
15%
Fistula
15%
Giant-Cell Arteritis
16%
Glaucoma
11%
Headache
19%
Idiopathic Intracranial Hypertension
19%
Ischemic Optic Neuropathy
21%
Leber Hereditary Optic Neuropathy
25%
Magnetic Resonance Imaging
36%
Meningioma
25%
Multiple Sclerosis
12%
Neoplasm
17%
Nerve Fiber Layer
20%
Nerve Paralysis
21%
Nerve Sheath
22%
Ophthalmic Vein
18%
Ophthalmoparesis
15%
Optic Disc
46%
Optic Nerve
93%
Optic Nerve Glioma
15%
Optic Nerve Sheath Meningioma
15%
Optic Neuritis
16%
Optic Neuropathy
100%
Optical Coherence Tomography
13%
Papilledema
36%
Photograph
27%
Physical Disease by Body Function
13%
Prevalence
18%
Radiation Therapy
17%
Retinal Nerve Fiber Layer
16%
Retrobulbar Optic Neuropathy
11%
Surgery
23%
Symptom
26%
Vision
15%
Visual Acuity
34%
Visual Field
30%
Visual Impairment
71%
Keyphrases
Anterior Ischemic Optic Neuropathy
14%
Artificial Intelligence
9%
Carotid-cavernous Fistula
12%
Cavernous Sinus
8%
Cerebrospinal Fluid
9%
Clinical Manifestations
10%
Confidence Interval
10%
Deep Learning
11%
Deep Learning System
12%
Disc Swelling
8%
Essential Blepharospasm
8%
Etiology
8%
Eye Fundus
9%
Fellow Eye
8%
Fundus Image
13%
Giant Cell Arteritis
13%
Headache
8%
Idiopathic Intracranial Hypertension
13%
Increased Intracranial Pressure
10%
Internuclear Ophthalmoplegia
9%
Ischemic Optic Neuropathy
9%
Leber Hereditary Optic Neuropathy
21%
Meningioma
13%
Multiple Sclerosis
15%
Neuro-ophthalmology
14%
Nonarteritic Anterior Ischemic Optic Neuropathy (NAION)
36%
Oculomotor Nerve Palsy
12%
Older Men
9%
Older Women
13%
Optic Disc
26%
Optic Nerve
55%
Optic Neuritis
25%
Optic Neuritis Treatment Trial
16%
Optic Neuropathy
36%
Optic Pathway Glioma
24%
Papilledema
24%
Progressive Visual Loss
9%
Proptosis
11%
Pseudotumor Cerebri
12%
Radiation Therapy
9%
Relative Afferent Pupillary Defect
13%
Superior Ophthalmic Vein
9%
Tumor
12%
Vision Loss
17%
Visual Acuity
34%
Visual Field
20%
Visual Field Defect
22%
Visual Function
20%
Visual Loss
27%
Visual Outcome
19%